Imunon Inc (IMNN)
1.29
-0.02
(-1.53%)
USD |
NASDAQ |
May 02, 14:55
Imunon Cash and Short Term Investments (Quarterly): 15.70M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.70M |
September 30, 2023 | 19.38M |
June 30, 2023 | 24.01M |
March 31, 2023 | 31.18M |
December 31, 2022 | 32.75M |
September 30, 2022 | 37.35M |
June 30, 2022 | 42.11M |
March 31, 2022 | 41.31M |
December 31, 2021 | 49.39M |
September 30, 2021 | 54.51M |
June 30, 2021 | 58.36M |
March 31, 2021 | 52.76M |
December 31, 2020 | 17.16M |
September 30, 2020 | 18.34M |
June 30, 2020 | 25.45M |
March 31, 2020 | 15.63M |
December 31, 2019 | 14.86M |
September 30, 2019 | 18.81M |
June 30, 2019 | 21.72M |
March 31, 2019 | 23.74M |
December 31, 2018 | 27.61M |
September 30, 2018 | 21.95M |
June 30, 2018 | 26.20M |
March 31, 2018 | 20.70M |
December 31, 2017 | 24.17M |
Date | Value |
---|---|
September 30, 2017 | 2.685M |
June 30, 2017 | 3.629M |
March 31, 2017 | 4.470M |
December 31, 2016 | 4.304M |
September 30, 2016 | 8.700M |
June 30, 2016 | 14.47M |
March 31, 2016 | 14.31M |
December 31, 2015 | 20.06M |
September 30, 2015 | 24.35M |
June 30, 2015 | 30.73M |
March 31, 2015 | 30.01M |
December 31, 2014 | 36.86M |
September 30, 2014 | 43.61M |
June 30, 2014 | 49.77M |
March 31, 2014 | 51.86M |
December 31, 2013 | 42.87M |
September 30, 2013 | 45.21M |
June 30, 2013 | 48.73M |
March 31, 2013 | 45.57M |
December 31, 2012 | 23.03M |
September 30, 2012 | 22.55M |
June 30, 2012 | 24.00M |
March 31, 2012 | 24.59M |
December 31, 2011 | 30.30M |
September 30, 2011 | 21.41M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.86M
Minimum
Dec 2019
58.36M
Maximum
Jun 2021
31.09M
Average
25.45M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
Avalo Therapeutics Inc | 7.415M |
iBio Inc | 2.788M |
Ocugen Inc | 39.46M |
Petros Pharmaceuticals Inc | 13.34M |
Moderna Inc | 8.604B |